Trials / Recruiting
RecruitingNCT06411392
SBRT for Ventricular Arrhythmia
Stereotactic Antiarrhythmic Radiotherapy for Ventricular Arrhythmia in Austria (Austrian STAR)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Medical University of Graz · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate the safety and efficacy of STAR (Stereotactic Antiarrhythmic Radiotherapy) in patients with VT (ventricular tachycardia) who are unresponsive to standard treatments. Additionally, the planned study aims to provide further insights into the effects of STAR on VT burden, ICD interventions, and insights regarding late toxicities, particularly those related to the heart, which are currently not well understood.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Antiarrhythmic Radiotherapy | Patients with ventricular tachycardia will undergo cardiac stereotactic antiarrhythmic radiotherapy with a single fraction of 25 Gy to the arrhythmia substrate, as determined by electrophysiological cardiac mapping. |
Timeline
- Start date
- 2024-03-01
- Primary completion
- 2027-02-01
- Completion
- 2027-02-01
- First posted
- 2024-05-13
- Last updated
- 2024-05-13
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT06411392. Inclusion in this directory is not an endorsement.